Recall issued for dog and horse medication after fiberglass found in vials
A nationwide recall was issued for two lots each of canine and horse intramuscular joint injections after routine testing revealed fiberglass contamination.
A recall notice rarely makes for gripping reading. This one deserves a second look, because it exposes the quiet fragility inside a supply chain most people never think about: veterinary pharmaceuticals.
American Regent, Inc. has pulled two lots each of Adequan Canine Injection and Adequan i.m. Injection after routine testing found fiberglass floating in the vials. The products are intramuscular joint treatments for dogs and horses. The company states it has received no reports of injury, and it frames the action as precautionary. That is the standard script, and it is probably accurate.
What matters here is not the drama, but the mechanics. Fiberglass in an injectable is not a cosmetic flaw. It is particulate matter entering a sterile, parenteral product. The company's own notice lists the possible consequences: local irritation, swelling, inflammation, injection site pain, infection, or abscesses. For a veterinarian injecting a joint, that is a meaningful clinical risk, not a theoretical one.
The recall also reveals something about the manufacturing environment. Glass fibers in a vial typically point to a failure in the filling line or the glass container itself. That is a process control problem, and it suggests the contamination was caught by routine testing rather than by a complaint. The system worked, in other words, but only up to a point.
For the market, the signal is modest but real. Adequan is a branded product with a loyal veterinary following. A recall of this scale, limited to four lots, is unlikely to dent the manufacturer's balance sheet. But it does remind distributors, clinics, and pet owners that even established brands can ship a bad batch. The practical advice stands: check the lot numbers, discard affected vials, and contact a veterinarian if an animal shows symptoms.
There is no remote work angle here, and none should be manufactured. The story is what it is: a routine recall, executed with the usual caution, that quietly underscores how much of modern animal care depends on sterile manufacturing done right.